Stocksigma LogoStocksigma Logo

Lupin Launches World's First Fixed-Dose Triple Combination Inhaler for COPD in India

Lupin Limited launched Formoflo-G MDI on 6th Oct'26, the world鈥檚 first fixed-dose triple-combination metered-dose inhaler for chronic obstructive pulmonary

Lupin Launches World's First Fixed-Dose Triple Combination Inhaler for COPD in India

Lupin Ltd 路 Press Release 路 06 Oct 2026, 3:06 pm

Lupin Launches World's First Fixed-Dose Triple Combination Inhaler for COPD in India Lupin Limited launched Formoflo-G MDI on 6th Oct'26, the world鈥檚 first fixed-dose triple-combination metered-dose inhaler for chronic obstructive pulmonary disease (COPD) management, following DCGI approval. The product combines Glycopyrronium Bromide, Formoterol Fumarate, and Fluticasone Propionate into a twice-daily, single-strength inhaler to treat moderate-to-severe COPD. Targeting a domestic patient pool exceeding 55 million individuals, the launch enhances Lupin鈥檚 domestic respiratory portfolio, where it holds the #2 market rank according to IQVIA MAT Mar'26 data.

Original exchange filing (PDF)

More announcements from Lupin Ltd

All Lupin Ltd announcements